In the next five years, many NBS programs will have implemented a multiplex PCR, measuring TRECs simultaneously with KRECs and SMN1 introducing NBS for XLA and spinal muscular atrophy (SMA) [86]. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.